TABLE 2.
Survivors (n=29) | Nonsurvivors (n=14) | Total (n=43) | |
CT thorax | |||
Alveolar consolidation | 29 (100) | 14 (100) | 43 (100) |
Ground-glass opacities | 29 (100) | 14 (100) | 43 (100) |
Pneumothorax | 3 (10.3) | 2 (14.3) | 5 (11.6) |
Pneumomediastinum | 4 (13.8) | 4 (28.6) | 8 (18.6) |
Pulmonary embolism | 7 (24.1) | 5 (35.7) | 12 (27.9) |
Echocardiogram | |||
Left ventricular impairment | 1 (3.4) | 0 (0) | 1 (2.3) |
Right ventricular impairment | 3* (10.3) | 5* (35.7) | 8 (18.6) |
CT head | |||
|
3 (10.3) | 3 (21.4) | 6 (14.0) |
With sulcal effacement | 0* (0) | 2* (14.3) | 2 (4.7) |
|
1 (3.4) | 0 (0) | 1 (2.3) |
|
0** (0) | 3** (21.4) | 3 (7.0) |
Laboratory values# | |||
|
99 (92–102) | 95 (86–107) | 97 (89–106) |
|
0.8 (0.5–1.3) | 0.6 (0.4–0.8) | 0.6 (0.5–1.1) |
|
11.2 (9.2–19.3) | 17.8 (12.1–24.2) | 12.8 (9.2–22.5) |
|
247 (203–344) | 214 (121–329) | 245 (163–339) |
|
73* (53–192) | 169* (98–347) | 96 (66–237) |
|
16 (9–22) | 15 (12–20) | 15 (11–22) |
|
1903 (904–3800) | 2251 (1308–5435) | 1907 (1153–4083) |
|
291 (217–388) | 344 (328–361) | 326 (245–368) |
|
1.24* (0.76–6.43) (n=28) | 6.3* (2.99–16.27) | 3.96 (1.15–9.01) (n=42) |
|
9.5* (5.2–31.7) | 38.2* (10.9–60.5) | 11.7 (6.4–41.7) |
|
26 (16–40) (n=24) | 98 (25–132) (n=7) | 28 (15–70) (n=31) |
Data are presented as n (%) or median (interquartile range). CT: computed tomography #: Units for laboratory values: haemoglobin in g·dL−1, lymphocyte count in 109·L−1, platelet count per µL, creatinine/bilirubin µmol·L−1, ferritin in µg·L−1, C-reactive protein in mg·L−1, procalcitonin in ng·mL−1, d-dimer in mg·L−1 fibrinogen equivalent units and troponin in ng·L−1. *: p=0.01–0.05; **: p<0.01.